Charles Schwab Investment Management Inc Sage Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 408,576 shares of SAGE stock, worth $2.98 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
408,576
Previous 387,139
5.54%
Holding current value
$2.98 Million
Previous $7.25 Million
38.83%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding SAGE
# of Institutions
217Shares Held
48.2MCall Options Held
854KPut Options Held
195K-
Vanguard Group Inc Valley Forge, PA6.42MShares$46.8 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$40 Million0.99% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$38 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$32.5 Million0.81% of portfolio
-
State Street Corp Boston, MA2.47MShares$18 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $433M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...